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ABSTRACT 
 
Neural progenitor (NP) cells proliferate in the ventricular zone (VZ) of the neural tube and 
migrate towards the mantle layer (ML) upon neural differentiation. In order to produce the correct 
type and number of neurons at the right time, a precise control of the proliferation of neural 
progenitor (NP) cells and their differentiation is required. The Notch signaling pathway, through 
lateral inhibition, is involved in this balance, restraining NP differentiation. However, not much is 
known about Notch activity in single NPs, mainly regarding possible variations on Notch activity 
in each NP, and how this putative dynamic activity contributes to the maintenance of these cells 
in the undifferentiated state. In order to answer these questions, I used several ES cell lines 
expressing different reporters of Notch activity driven by the promoter of the Hes5 gene. These 
ES cells can be directed to neural differentiation in adherent monolayer cultures, resulting in the 
production of neuroepithelial rosettes that mimic their in vivo counterpart, the neural tube. Here, I 
show that an already described Hes5::GFP reporter ES cell line is not suitable to be used as a 
reporter of Notch activity since the half-life of the reporter protein is much longer than that of the 
HES5 protein, not allowing the detection of the termination of Notch activity. I also test other ES 
cell lines, Hes5::VNP, that express an unstable reporter protein, which might allow a more 
precise and accurate monitoring of Notch activity dynamics. Using this cell lines, I could observe 
that not all cells in neuroepithelial rosettes express the reporter protein, and that the levels of 
Notch activity are variable between NPs. Further engineering of these cell lines needs to be 
performed in order to be able to construct a double reporter cell line carrying a reporter of Notch 
activity together with a reporter of neuronal differentiation to allow visualization of differentiated 
neurons.   
 
 
 
 
Key-words: Notch signaling, HES5 reporter protein, neuroepithelial rosette, Neural 
progenitors, Interkinetic nuclear migration.  
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RESUMO 
 
O tubo neural, estrutura embrionária que no adulto origina o sistema nervoso central, 
encontra-se organizado em duas zonas: a zona ventricular, onde residem os progenitores 
neurais, e a zona do manto, para onde migram estas células quando começam a diferenciar em 
neurónios. Os núcleos dos progenitores neurais movimentam-se entre as regiões apical e basal 
da zona ventricular num mecanismo designado de movimento intercinético nuclear. Este 
movimento encontra-se relacionado com as fases do ciclo celular, sendo que a mitose ocorre 
quando o núcleo dos progenitores neurais se encontra na região apical e a fase S quando este 
se encontra na região basal. Durante a neurogénese é necessária a existência de um controlo 
preciso entre a manutenção de células num estado indiferenciado e a diferenciação destes 
progenitores em células neurais. Sabe-se que a via de sinalização Notch está implicada neste 
balanço através do processo de inibição lateral, restringindo a diferenciação das células 
progenitoras. Inicialmente todas as células expressam níveis semelhantes de ligandos Notch e 
genes pró-neurais. Contudo, devido a variações estocásticas, uma das células começa a 
expressar níveis mais elevados de ligandos Notch e consequentemente é mais eficiente na 
activação de Notch nas células vizinhas. Nas células em que Notch é activado há expressão de 
genes Hes que reprimem a expressão de genes pró-neurais e levam à consequente 
manutenção dessas células como progenitores neurais. Por sua vez, nas células que não 
activaram Notch ocorre a expressão de genes pró-neurais com consequente diferenciação dos 
progenitores neurais.  
Após a migração dos neurónios nascentes para a zona do manto, estas células deixam de 
sinalizar para as células adjacentes. Desta forma a actividade de Notch diminui nos 
progenitores neurais vizinhos e o processo de inibição lateral poderá ser reiniciado. Assim, os 
níveis de Notch em progenitores neurais não deverão ser constantes e a sinalização Notch será 
dinâmica. A actividade dinâmica da via de sinalização Notch foi monitorizada na mesoderme 
pré-somítica e em culturas de progenitores neurais isolados utilizando uma proteína reporter 
instável sob o controlo do promotor de um gene alvo de Notch: Hes1. A utilização deste repórter 
permitiu observar variações na expressão de Hes1. Contudo, foi observado que a expressão de 
Hes1 não é apenas dependente da actividade da via Notch, respondendo a outras vias de 
sinalização como a via Jak/Stat, o que impossibilita a monitorização apenas da actividade da 
via de sinalização Notch. 
Uma outra observação concordante com a actividade dinâmica de Notch é a expressão de 
componentes da via Notch em gradientes entre as regiões apical e basal da zona ventricular, 
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sugerindo que nos progenitores neurais a activação de Notch é específica de determinadas 
fases do ciclo celular. Em retina de peixe zebra foi observado que o receptor Notch activado é 
expresso em níveis elevados na região apical, onde os progenitores se encontram nas fases 
G2/M/G1 do ciclo celular. Contudo, em cérebro de ratinho o receptor Notch activado foi 
detectado em células em fase S do ciclo celular e não em mitose. No tubo neural de galinha o 
mRNA de Notch foi detectado na região apical da zona ventricular, onde ocorre a mitose. Estes 
resultados contraditórios podem indicar regulações diferentes da actividade Notch em diferentes 
organismos e tecidos. Desta forma, uma análise mais profunda é necessária para determinar se 
a activação de Notch ocorre especificamente em determinadas fases do ciclo celular. Por outro 
lado é necessária a análise de progenitores neurais ao nível de células individuais recorrendo a 
um repórter que responda apenas a Notch. Apenas desta forma será possível determinar se 
Notch pode ser activado mais do que uma vez no tempo de vida de cada progenitor neural e se 
a sua actividade é necessária para manter estes progenitores neurais num estado 
indiferenciado.   
Neste trabalho utilizaram-se várias linhas celulares de células estaminais embrionárias 
(Hes5::GFP and Hes5::VNP) que expressam diferentes proteínas repórter sob o controlo do 
promotor do gene Hes5, que se pensa ser o principal alvo da via Notch no sistema nervoso 
central. Estas células estaminais embrionárias podem ser diferenciadas em tecido neural, 
através de um protocolo de cultura de células aderentes em monocamada, formando estruturas 
características designadas rosetas neuroepiteliais, onde a expressão de Hes5 foi já 
documentada.  
A linha celular Hes5::GFP já tinha sido descrita e foi testada relativamente às suas 
capacidades de auto-renovação e pluripotência tendo-se observado que não diferia da linha 
celular controlo. Adicionalmente, a sua capacidade de diferenciação neural e a expressão da 
proteína repórter foram testadas tendo-se confirmado a capacidade de originar rosetas 
neuroepiteliais em que a expressão da proteína repórter estava presente. O tempo de semi-vida 
da proteína repórter foi determinado de forma a avaliar se esta linha celular iria permitir a 
monitorização e determinação do início e terminação da actividade da via Notch. Observou-se 
que 12 horas após o bloqueio da tradução as células ainda exprimem cerca de 75% do valor 
inicial de proteína repórter GFP. Dado que o tempo de semi-vida da proteína HES5 é de 
aproximadamente 1 hora foi possível concluir que esta linha repórter não pode ser usada para 
monitorizar a actividade Notch uma vez que permanece nas células durante muito tempo após 
a sua terminação.  
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Foram geradas no Laboratório linhas celulares que expressam uma proteína repórter instável 
sob controlo do promotor do gene Hes5 de forma a possibilitar a detecção do começo e 
terminação da actividade Notch. Estas linhas foram validadas em termos de capacidade de 
auto-renovação e pluripotência tendo-se observado que as suas características não diferiam 
daquelas da linha celular controlo. Adicionalmente, foi confirmada a capacidade de formação de 
rosetas neuroepiteliais e expressão da proteína repórter. Das linhas geradas a linha Hd foi 
escolhida para continuar as experiências tendo-se observado que a intensidade de expressão 
do repórter não é igual em todas as células das rosetas originadas por estas células. Este 
resultado sugere que a intensidade da actividade Notch varia entre os progenitores neurais. 
Este facto pode ser explicado pelo facto de a expressão de Notch ser constante em cada célula 
mas variar entre diferentes células, ou pelo facto de esta expressão ter variações na mesma 
célula. De realçar ainda que estes resultados sugerem possíveis flutuações na actividade da via 
Notch, enfatizando a importância da monitorização de Notch ao nível de um único progenitor 
neural.  
A linha celular Hd, possui a sequência do gene de resistência à Neomicina localizada entre a 
região codificante da proteína VNP e a região 3‟UTR do gene Hes5, onde se localiza o sinal de 
poli-adenilação necessário para a produção de um transcrito com todos os sinais de regulação 
pós-transcricional necessários. Desta forma procedeu-se à remoção do gene de resistência à 
Neomicina de forma a assegurar a correcta expressão da proteína repórter. Contudo, nas linhas 
celulares obtidas após este procedimento não se observou expressão da proteína reporter. 
Após vários testes à sequência promotora e à expressão do repórter ao nível de mRNA e 
proteína concluiu-se que a falta de expressão do repórter deveria dever-se a problemas a nível 
da transcrição. De forma a ultrapassar estes constrangimentos novas linhas celulares deverão 
ser desenhadas e geradas de forma a que o cDNA da proteína reporter possua o seu próprio 
sinal de poliadenilação antes de se proceder à remoção da cassete de selecção. Desta forma a 
expressão da proteína repórter poderia ser analisada imediatamente aquando da geração das 
linhas sem serem necessários procedimentos adicionais de remoção da cassette de selecção, 
que acarretam a possibilidade de introdução de instabilidade genómica e danos no DNA. 
Após a construção de linhas Hes5::VNP capazes de monitorizar de forma fiel a actividade da 
via Notch será possível monitorizar esta actividade em progenitores neurais ao nível de células 
individuais. Assim será possível determinar se Notch pode ser activado várias vezes ao longo 
do tempo de vida destas células e especificamente em determinadas fases do ciclo celular e se 
essa activação está correlacionada com a manutenção das células num estado indiferenciado. 
Adicionalmente, estas linhas celulares podem ser usadas para a formação de uma dupla linha 
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repórter que expressa repórteres da actividade Notch e também de diferenciação. Desta forma 
será possível avaliar não só as variações na actividade da via Notch mas também diferenciação 
neuronal, correlacionando a actividade Notch com o destino celular dos progenitores neurais. 
 
 
 
Palavras-chave: Via de sinalização Notch, Proteína repórter HES5, Roseta neuroepitelial, 
Progenitores neurais, Movimento Intercinético nuclear.  
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1. INTRODUCTION 
1.1 The Neural tube and the Neuroepithelium 
In vertebrates, the process of neurulation gives rise to the neural tube, a structure that 
develops into the adult central nervous system (brain and spinal cord). Production of neurons 
occurs in the neural tube by means of an asynchronous and mitotically active neuroepithelial 
population [2]. These neural progenitor (NP) cells are located in the ventricular zone (VZ), 
migrating away to the mantle layer (ML) upon neuronal differentiation (Figure 1).  
 
Figure 1: The neural tube and interkinetic nuclear migration. The neural tube is divided into two major regions: the 
VZ, where NPs reside, displaying the characteristic INM, and the ML, to where cells migrate when they differentiate. 
The nucleus of a NP migrates within the cytoplasm (INM) according to the phases of the cell cycle being at the basal 
region of the VZ during S-phase and at the apical region of the VZ during mitosis. Adapted from Kosodo et al, 2011. 
The VZ is pseudostratified, with NPs being attached to both the outer basal and inner apical 
surfaces. The nucleus of a NP migrates within the cytoplasm in a characteristic movement 
between the apical and basal regions of the VZ (Figure 1), called interkinetic nuclear migration 
(INM), that was first described by Sauer in 1935 (reviewed in [3], [4]).  
A key feature of INM is that nuclear migration is correlated with the phases of the cell cycle of 
NPs, with mitosis occurring when the nucleus is located at the apical region of the VZ, and S-
phase when it is at the basal region (Figure 1) (reviewed in [4], [5]). However, the mechanisms 
involved in the coordination between INM and the cell cycle are not clear. It has been reported 
that inhibition of INM by inhibiting actin or microtubule polymerization does not influence cell 
cycle progression. In contrast, INM stops when the cell cycle is blocked [2], (reviewed in [3]). 
These results suggest that the regulators of the cell cycle also regulate the molecular machinery 
involved in nuclear migration but the contrary does not seem to occur with nuclear migration not 
being necessary for cell cycle progression. Recently, a molecular mechanism connecting cell 
cycle to INM was described [6]. In this study, the microtubule-associated protein Tbx2 was 
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reported to be translocated to the apical process of NPs during G2 phase, ensuring the proper 
movement of nuclei to the apical region during the appropriate cell cycle phase (S-G2-M 
transition).  
Regarding INM functions, it has been suggested that it might act to increase the density of 
proliferating NPs while maintaining their apical and basal attachments during mitosis and 
consequently junction-associated signaling molecules. Another possible function for INM is a 
role in the determination of cell fate diversification of NPs (reviewed in [3]). Cell fate 
determinants, such as Notch or Delta1 are expressed specifically in the apical or basal regions 
of the VZ [7] and consequently INM may generate heterogeneity between NPs, according to the 
differential nuclear positions (reviewed in [3]).  
NPs in the VZ can undergo different types of cell division: proliferative symmetric cell 
divisions (PP division), expanding the pool of NPs, and asymmetric or symmetric neurogenic cell 
divisions (PN and NN divisions, respectively), which generate neurons (reviewed in [9], [10]) 
(Figure 2). 
 
Figure 2: Types of cell division of NP cells. The scheme summarizes the types of cell division that NPs can 
undergo. (A) Symmetric cell division originating two neural progenitors (PP). (B) Symmetric cell division originating 
two neurons (NN). (C) Asymmetric cell divisions originating one neural progenitor and one neuron (PN). 
It has been observed a correlation between the type of cell division and the angle of the 
mitotic cleavage plane relative to the lumen of the VZ. NN cell divisions were reported to be 
generated by vertical cleavage planes, while PP and PN divisions can occur in all orientations, 
suggesting that cleavage plane orientation would only be important in cells with potential to 
generate neurons [10]. Regarding PN cell divisions, it has been observed that asymmetric 
inheritance of the apical membrane is indicative of asymmetric daughter cell fates [8], [11]. It 
was therefore suggested that the correlation between the angle of mitotic cleavage plane and 
the type of cell division involves the distribution of the apical elements of the dividing cell 
between the two daughter cells: vertical cleavage planes would bisect the apical elements 
(distributing them equally to the daughter cells) while horizontal cleavage planes would bypass 
them (resulting in an unequal distribution of the apical elements) (reviewed in [9]). Contradictory 
data has been published regarding the cell fate of the cell that inherits the apical membrane: 
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some results suggest that the daughter cell that inherits it is going to be maintained as a 
progenitor cell [8], while others suggest that the cell that inherits the apical membrane is going to 
differentiate into a post-mitotic neuron [11]. In addition, it has also been reported that the length 
of the G1 phase of the cell cycle might play an important role in the type of cell division that NPs 
undergo [6], (reviewed in [12], [13]). NPs that undergo PN cell divisions have a longer G1 phase 
than the ones that undergo PP cell divisions suggesting that the lengthening of G1 in 
neuroepithelial cells is correlated with the neurogenic potential [10]. Further analysis of the cell 
cycle and the type of cells generated will be essential to better elucidate their relation and clarify 
previous contradictory reports. 
1.2 Notch pathway in vertebrate neurogenesis 
During neurogenesis, a balance between the proliferation of NPs and their differentiation into 
neurons needs to be maintained, in order to produce the correct number and types of neurons at 
the right time. It is known that the Notch pathway, a highly conserved mechanism among 
metazoans, is implicated in this process, controlling cell fates through cell interactions (reviewed 
in [14-16]). The Notch receptor gene was first characterized in Drosophila melanogaster and 
encodes a cell surface type I transmembrane protein with an extracellular ligand-binding domain 
and a cytoplasmic domain that acts in signal transduction. The extracellular domain comprises 
epidermal growth factor (EGF)–like tandem repeats, thought to be involved in ligand binding, 
and a cystein-rich conserved region that appears to negatively regulate receptor activation 
(reviewed in [17]). In the cytoplasmic domain there are 6 tandem ankyrin repeats (that are 
sufficient for Notch activity), a glutamine-rich domain, and a PEST sequence that is involved in 
Notch protein turnover (reviewed in [14], [17]). The Notch receptor is subjected to post-
translational modifications in the trans-Golgi network by proteases of the Furin-family, and is 
then translocated to the plasma membrane where it works as an heterodimer that comprises an 
ectodomain and a membrane tethered intracellular domain (reviewed in [18]). The Notch ligands 
are also type I transmembrane proteins of the DSL family (invertebrate ligands Delta, Serrate 
and LAG-2). Similar to the Notch receptors, members of the DSL family of Notch ligands have 
multiple (EGF)–like tandem repeats in the extracellular domain, but unlike the receptor they have 
characteristic degenerate N-terminal EGF repeats. The Notch ligands do not share the same 
functions between themselves, as they seem to regulate different developmental decisions 
(reviewed in [17]).  
Upon ligand-receptor interaction, the Notch receptor undergoes a series of proteolytic 
cleavages mediated by a ɣ-secretase complex, resulting in the release of the Notch intracellular 
domain (NICD) to the cytoplasm. NICD is then translocated to the nucleus, where it binds CSL 
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(a DNA-binding protein) and recruits Mastermind, forming a ternary complex. In the absence of 
NICD, CSL binds to specific regulatory regions, acting as a repressor. Upon Notch activation, 
the complex suffers conformational changes replacing the co-repressors by transcriptional co-
activators (such as Mastermind), which activate the expression of Notch target genes (reviewed 
in [15], [18], [19]). The main Notch targets are the HES genes that encode basic helix-loop-helix 
(bHLH) transcriptional repressors. The HES proteins repress the expression of proneural bHLH 
genes (like Mash1 or Neurogenin2) that are responsible for the induction of the neural 
differentiation program (reviewed in [15], [20]) (Figure 3). 
 
Figure 3: A scheme representing the Notch signaling pathway. The proneural genes (like Mash1 and Ngn2) 
induce the expression of Notch ligands (like Delta1), activating Notch in the neighboring cells. In these cells, the 
receptor-ligand interactions trigger a series of proteolytic cleavages that result in the release of NICD. NICD is then 
translocated into the nucleus where it forms a complex with RBPj (CSL). NICD/RBPj complex functions as a 
transcriptional activator of Notch target genes (like the Hes genes). The Hes genes, in turn, inhibit their own 
expression and the  expression of proneural genes. As a result, cells where Notch is not activated express proneural 
genes and differentiate into neurons while in cells that have activated Notch, proneural gene expression is repressed 
and therefore these cells are maintained as progenitors. Adapted from Kageyama 2008. 
The Notch pathway ensures the generation of cells with different fates in a population of cells 
that have similar developmental potential by the mechanism of lateral inhibition (reviewed in [18], 
[19], [21]). By this mechanism, one cell is chosen from a group of equivalent cells to acquire one 
determined cell fate and by competing with its neighbors inhibits them from acquiring the same 
fate (reviewed in [16], [19]). Initially, in the vertebrate neural tube, all cells are equivalent, 
expressing similar levels of both Notch ligands and proneural genes (Figure 3). At a certain 
point and due to stochastic variations, one cell starts to express higher levels of Notch ligands 
(signal sending cell) and consequently becomes more effective at activating Notch in 
neighboring cells. The signal receiving cells activate the expression of Notch target genes (like 
the Hes genes) that are going to repress the expression of proneural genes and Notch ligands. 
Consequently, signal receiving cells have lower levels of proneural gene expression and are 
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maintained as progenitor cells. In contrast, signal sending cells up-regulate the expression of 
proneural genes, differentiating into post-mitotic neurons (reviewed in [15], [20-22]). 
In differentiating neurons ligand expression is transient, being down-regulated upon cell 
migration from the VZ to the ML. As a consequence, the levels of Notch activity in the 
neighboring cells are reduced, the lateral inhibition process is reset and NPs are able to respond 
to new signals and to decide again if they enter differentiation or are maintained as NPs. This 
suggests that Notch activity levels in NPs are not constant and that Notch signaling might be 
dynamic. The dynamic nature of Notch signaling has already been observed in different systems 
by the detection of fluctuations or oscillations in Notch target genes. It was observed that the 
bHLH component of Notch pathway, Hes1, is cyclically expressed in the presomitic mesoderm 
[23]. Hes1 expression fluctuations were also observed in isolated NP cultures [24]. However, it is 
known that other signaling pathways, like the Jak/Stat pathway, are implicated in Hes1 
fluctuations [24], (reviewed in [20], [25]), and therefore Hes1 expression is not a specific readout 
of Notch activity.  
In agreement with the dynamic activity of Notch signaling, Notch components were reported 
to be expressed in apical-basal gradients in the VZ of the neural tube, suggesting that NPs are 
able to activate Notch only in specific phases of the cell cycle. In the developing zebrafish retina, 
the activated form of the Notch receptor is expressed at higher levels in the apical region of the 
neuroepithelium, where NPs are at G2/M/G1 phases of the cell cycle, while Delta1 mRNA is 
expressed at higher levels at the basal region [26]. It was suggested that the INM regulates the 
duration and level of exposure of NPs to Notch signaling in the apical region of the VZ: in retinas 
of zebrafish mutants for the microtubule motor associated protein Dynactin-1, NPs nuclei move 
more quickly and deeply to the basal region of the VZ and more slowly to the apical region, 
resulting in less exposure to Notch signaling and a consequent premature exit of NPs from the 
cell cycle, leading to massive neuronal differentiation [26]. In the VZ of the developing chick 
neural tube similar patterns of expression of Notch components were also observed, with Notch1 
mRNA being expressed specifically in the apical region [7]. In the developing chicken brain it 
was observed that Notch mRNA expression is reduced in S-phase [7], [27]. These results 
suggest that Notch activity occurs distinctively in a specific region of the neuroepithelium where 
cells undergo mitosis. However, in the developing mouse brain, the activated form of the Notch 
receptor is not detected in the apical region of the VZ. Instead, it is detected in S-phase cells, 
suggesting that Notch is not activated in mitosis [28]. These contradictory results might indicate 
different regulations of Notch activity in different tissues and organisms.  
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Further analysis of Notch activity in NPs is thus necessary to determine whether activation 
occurs in specific cell cycle phases. Also, analysis of single NPs using a bona fine readout that 
responds only to Notch signaling is essential to assess if the Notch pathway can be activated 
more than once in the NPs life-time and if Notch activation is necessary to maintain these NPs in 
an undifferentiated state.  
1.3 Embryonic Stem cells 
Embryonic Stem (ES) cells are derived from the inner cell mass of embryos in the blastocyst 
stage (reviewed in [29]) and are characterized by their self-renewal capacity (being able to 
proliferate indefinitely under the appropriate conditions) and their pluripotency capacity (giving 
rise to all cell types from the three germ layers - ectoderm, endoderm and mesoderm) (reviewed 
[30]). Initially, the maintenance of mouse ES cells in culture was dependent on a proper medium, 
containing the necessary metabolites, nutrients and serum and also on the presence of feeder 
cells. Currently, it is known that feeder cells can be replaced by a specific cytokine, leukaemia 
inhibitory factor (LIF) and serum by BMP4 (reviewed in [31], [32]). Upon withdrawal of LIF, cells 
lose their undifferentiated characteristics and rapidly differentiate (reviewed in [32]). Due to their 
unique properties, ES cells have been used as a powerful tool for the development of cell-based 
therapies, generation of cellular disease models, test of new drugs and also to unravel the 
molecular mechanisms and pathways involved in the differentiation fate of a pluripotent cell 
(reviewed in [30], [34]). 
ES cells can be driven into neural differentiation by the formation of multicellular aggregates, 
embryoid bodies (EBs), or by adherent monolayer cultures [35-37]. However, neural 
differentiation of ES cells mediated by EBs formation is very inefficient, occurring only in a small 
fraction of cells [36]. A more efficient method to drive neural differentiation of ES cells relies 
upon adherent monolayer cultures and was firstly described in 2003 by Ying and co-workers 
[36]. In this protocol, ES cells are cultured in feeder-free conditions in the presence of a serum-
free medium that does not contain LIF or BMPs, which are known to inhibit neural differentiation. 
Therefore, cells leave the undifferentiated state, passing through successive stages from an 
identity of ES cells to NPs and organize in rosette-like structures [35] (Figure 4). These rosettes 
have been shown to mimic the in vivo neural tube as they show: (i) proper apico-basal polarity, 
with apical markers localizing at the centre of the rosette and differentiating neurons migrating to 
the outer surface of the rosette; (ii) proper cell cycle stage localization, with mitosis occurring at 
the apical surface (centre) of the rosette and S-phase at the periphery, reproducing the 
characteristic INM observed in the VZ of the vertebrate neural tube; (iii) active Notch signaling in 
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NPs but not in differentiated cells; and (iv) proper timing of production of neurons and glia. 
Additionally, as rosettes are two-dimensional structures, they are much easier to analyze and to 
image than their embryonic counterpart, being a useful tool to study Notch activity in single cells.  
 
Figure 4: Schematic representation of the successive competence states acquired along the monolayer 
neural differentiation protocol. During neural differentiation ES cells pass through successive states of competence. 
ES cells initially acquire characteristics of Primitive Ectoderm (Pr.Ectoderm). Then, a transient population of NPs 
(tNPs) emerges and gives rise to a NPs population that is able to originate neurons (nNPs). This population of NPs 
will then originate the final set of NPs organized in rosette-like structures having proper Notch activity, INM and 
production of differentiated neurons. Adapted from Abranches et al 2009. 
ES cells can be modified to generate ES cell lines expressing reporter proteins (like GFP) 
under the control of specific promoters, allowing to monitor gene expression in live ES cells [1], 
(reviewed in [37]). To generate reporter ES cell lines there are several aspects to consider: (i) 
the promoter used to drive the expression of the reporter protein; (ii) the type of reporter protein 
that is going to be used; and (iii) the strategy to engineer the desired cell line. 
Reporters of Notch signaling have been described to use either synthetic promoters (repeats 
of CSL binding-boxes) [39] or promoters of Notch target genes (like Hes1 or Hes5) [1], [23], [24], 
[40] to drive the expression of the reporter proteins. Expression of reporter proteins driven by 
synthetic promoters does not reflect all Notch activity [39]. Therefore, the use of Notch target 
genes seems to be a better choice. Among the Notch target genes, it has been shown that Hes1 
expression is not affected by the inactivation of the Notch pathway in the developing embryo [41] 
and does not respond specifically to Notch signaling [24]. In contrast, Hes5 expression is 
dramatically reduced in Notch mutants [41], suggesting that Hes5 is a specific Notch target gene 
in the developing nervous system. Therefore, Hes5 promoter would be the most appropriate to 
use as readout of Notch activity.  
The characteristics of the reporter protein to be used in the generation of this reporter cell line 
are very important. One of the most relevant features of the reporter protein is its half-life. 
Ideally, the reporter protein should have the same half-life as that of the protein coded by the 
gene that is going to be monitored, so that the onset and termination of expression can be 
observed. This is particularly important for proteins with short half-lives, such as the HES5 
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protein that has a half-life shorter than 1hr [42]. In this case an unstable reporter protein should 
be used to visualize its expression. The reporter should be unstable both at the protein and 
mRNA levels so that it allows the precise monitoring of Notch activity.  
Transgenic ES cells can be generated by different methods: (i) site-specific targeting of the 
cDNA encoding a reporter protein into the locus of the gene of interest or (ii) random integration 
into the genome of the potential regulatory regions of the gene of interest linked to a cDNA 
encoding a reporter protein. The first method has the advantage of normally resulting in a 
correct expression of the reporter. However, the process is very inefficient and results in a cell 
line with only one functional allele of the targeted gene. In the second method, in which a 
potential regulatory region linked to a cDNA encoding a reporter protein is randomly integrated 
into the genome, the expression of the reporter is frequently influenced by the chromosome 
integration site. Furthermore, this strategy normally requires that the promoter and other 
regulatory regions of the gene of interest are known.  
One method that allows overcoming these limitations is the use of Bacterial Artificial 
Chromosome (BAC) vectors expressing the reporter protein. A BAC is a DNA construct based 
on the conjugation plasmid (F plasmid) of E. coli that can be electroporated into ES cells. These 
vectors carry long genomic regions, containing entire genes as well as distant flanking cis-
regulatory regions that are necessary for proper gene regulation and expression (reviewed in 
[43]). BACs can be modified to express a reporter protein with all the regulatory sequences of 
the gene of interest, allowing the monitor of gene expression. This is very important because 
reporters of Notch activity driven by a 0.76-Kbp promoter of Hes5 showed not to fully mimic the 
expression of the endogenous Hes5 gene [44]. The large size of these BAC vectors also 
diminishes the effects of the integration site on reporter expression [43]. Besides these 
advantages, as BAC vectors integrate randomly into the genome they do not disrupt the 
endogenous copies of the gene of interest.  
The generation of a reporter using a BAC vector comprises several successive steps: (i) 
choice of a BAC vector that comprises the coding region of the gene of interest and the largest 
possible flanking regions; (ii) generation of the reporter cassette (in a plasmid) containing the 
cDNA encoding the reporter protein, appropriate selectable markers and homology regions that 
are needed for a step of homologous recombination in E.coli; (iii) BAC recombineering 
(homologous recombination) performed in bacteria, replacing the coding region of the gene of 
interest in the BAC by the reporter cassette DNA, present in the plasmid; (iv) purification of the 
modified BAC; and (v) its electroporation into ES cells and the creation of a stable cell line 
(reviewed in [45], [46]). This strategy has already been used to generate reporter systems of 
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Notch signaling [1], [40]. Specifically, Tomishima and co-workers engineered an ES cell line 
(Hes5::GFP, from here on referred as HT cell line) expressing a stable reporter protein (GFP) 
under the control of the Hes5 promoter [1].  
A reporter of Notch activity has also previously been generated in the Laboratory using the 
promoter of the Hes5 gene and BAC recombineering strategy (Hes5::VNP cell line). In contrast 
with the reporter protein employed in the HT cell line, the reporter protein of the Hes5::VNP cell 
line is unstable, comprising Venus (a yellow fluorescent reporter protein), NLS (a nuclear 
localization signal that targets the reporter protein to the nucleus) and PEST (a peptide 
sequence that reduces the half-life of the protein to which it is fused). This reporter protein is 
based on an already described Venus-PEST unstable reporter [47] that allows monitoring of 
2hrs periodic waves of Lfng reporter expression. Also, Hes5::VNP cells express an unstable 
reporter mRNA due to the presence of post-transcriptional regulatory signals in the 3‟UTR, which 
decreases the time of reporter activity.  
Thesis Outline 
The objective of this thesis is to monitor Notch activity in live neural progenitors, in order to 
investigate the role of Notch signaling during vertebrate neural development. The specific aims 
were: 
- Determine if Notch is activated more than once in a life of a NP; 
- Determine if Notch activation occurs preferentially in a specific phase of the cell cycle; 
- Define the timing of commitment to neurogenesis;  
- Assess if Notch activity is correlated with the cell fate of NPs. 
In order to do so, a previously described ES cell line expressing a fluorescent reporter protein 
under the control of the Hes5 promoter (HT) [1] was analyzed to assess its suitability to perform 
these experiments. Specifically, the stability of the reporter protein (GFP) was investigated by 
determination of its half-life. In addition, the novel ES cell lines generated in the Laboratory were 
also investigated for their suitability as reporters of Notch activity. These cell lines, (Hes5::VNP), 
express an unstable reporter protein upon Notch activation, which might allow the precise 
monitoring of Notch activation and termination in NPs, in real-time and with single cell resolution.
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2. MATERIALS AND METHODS 
2.1 Materials /Reagents  
2.1.1 Embryonic stem cell lines 
The mouse ES cell lines used in this project are listed in Table S2 (Chapter 6). 
2.2.2 Reagents 
The reagents, solutions/media, primers and antibodies used in this study are listed in Table 
S3, Table S4, Table S5 and Table S6, respectively (Chapter 6). 
2.2 Methods 
2.2.1 ES cell culture 
All steps involved in the manipulation of ES cells were performed in a sterile laminar flow 
hood class II, type A/B3. 
2.2.1.1 Expansion of ES cells 
ES cells were thawed in pre-heated Glasgow Modified Eagles Medium 1x (GMEM) and 
plated on 0.1% (v/v) gelatin-coated dishes in supplemented GMEM (with 2ng/ml LIF). Medium 
was changed 6hrs later to eliminate DMSO residues. ES cells were grown at 37ºC in a 5% (v/v) 
CO2 incubator on gelatin-coated dishes in supplemented GMEM. The morphology and health of 
the cells were assessed daily by direct visualization on a bright field microscope and cells were 
passaged every other day, at a constant plating density of 3x104 cells/cm2. For each passage, 
cells were washed twice with PBS and dissociated with 0,025% trypsin for 2-3min at 37ºC. Cells 
were immediately resuspended in GMEM (in order to neutralize trypsin), centrifuged at 1200 rpm 
for 4min and again resuspended in GMEM. Cells were counted using trypan blue dye exclusion 
method and the required amount of cells was then plated on gelatin-coated dishes in 
supplemented GMEM. To prepare ES cell stocks, 3x106 cells were frozen in GMEM 1x with 10% 
Dimethyl sulphoxide (DMSO) and stored in liquid N2. Every time cells were frozen, a sample was 
collected to test for Mycoplasma contamination (see section 2.2.5.2).  
2.2.1.2 ES cell differentiation 
2.2.1.2.1 Embryoid Bodies formation  
To generate EBs, ES cells were plated at 2x104 cells/cm2 in GMEM 1x on bacterial grade 
dishes. EB formation was checked on day 1 and the morphology was assessed every day, until 
day 8, to confirm the normal differentiation pattern of the cultures. 
2.2.1.2.2 Neural differentiation in adherent monolayer cultures  
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The protocol described in Abranches et al. was used (Figure 4) [35]. Briefly, 24hrs before the 
beginning of the monolayer differentiation protocol (day -1), cells were plated at high density 
(1x105 cells/cm2) on gelatin-coated dishes in serum-free medium (ESGRO Complete Clonal 
Grade medium) supplemented with 2ng/ml of LIF. After 24hrs (day 0), cells were observed on a 
bright field microscope to assess morphology and confluence of the cultures. Cells were then 
dissociated, counted and plated on fresh gelatin-coated dishes in RHB-A medium at a cell 
density of 3x104 cells/cm2. Medium was changed at day 2 and cells were replated at day 4. For 
the replating, cells were dissociated, counted and plated at a cell density of 2x104 cells/cm2 on 
PDL-Laminin coated tissue culture plastics or coverslips in RHB-A supplemented with 5ng/mL of 
murine bFGF and medium was changed at day 6. According to the analysis to be made, at the 
end of the neural differentiation protocol (day 8) different cell treatments were performed (see 
sections 2.2.3.2, 2.2.4.1, 2.2.3.3).  
2.2.1.2.2.1 PDL-Laminin Coating  
The tissue culture dishes or coverslips were covered with PDL solution (10µg/mL in PBS) and 
were left for 1h at room temperature (RT). The dishes were then washed twice with PBS, 
covered with Laminin solution (2,5 µg/mL in PBS) and left overnight (O/N) at 37ºC and 5% CO2. 
Laminin was removed immediately before plating the cells.  
2.2.2 ES cell line generation 
2.2.2.1 BAC electroporation into ES cells 
In this work were used ES cell lines that had been previously generated in the Laboratory. 
These cell lines were engineered, by the insertion of a BAC vector, to express a reporter protein 
driven by the promoter of the Hes5 gene. The BAC was chosen from the CHORI database 
(REF. RP24-345H15), comprising the Hes5 coding region and the largest possible flanking 
regions. The BAC was manipulated through recombinogenic engineering (reviewed in [46]), 
replacing the coding region of the Hes5 gene by the reporter cassette DNA. This reporter 
cassette contains the cDNA of the reporter protein followed by a Neomycin resistance cassette 
flanked by loxP sites. The reporter protein (VNP) has unstable kinetics, comprising Venus, a 
yellow fluorescent reporter protein with bright signal and fast maturation, NLS, a nuclear 
localization signal that targets the reporter protein to the nucleus and PEST, a peptide sequence 
that reduces the half-life of the proteins to which it is fused. The modified BAC vector was 
electroporated into E14tg2a ES cells, integrating randomly and in a stable manner in the 
genome. After electroporation, clonal ES cell lines were generated. 
2.2.2.2 Selection cassette removal from ES cells 
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Cells were dissociated (section 2.2.1.1) and 5x106 cells were resuspended in ice cold PBS. 
Cells were electroporated with 0.5µg of pCAGGsPuromycin and 50µg of pTurboCre, at 400V, 
250µF. After the electroporation procedure, cells were left for 10min at RT and plated in GMEM 
on gelatin-coated dishes. Medium was changed 6hrs later to supplemented GMEM. Selection 
started in the next day, by adding 2µg/µL of Puromycin to the medium, and lasted for two days. 
After that, medium was changed every day for 9 days. Subsequently, 24 individual colonies of 
cells were manually picked and grown clonally. Genomic DNA from each clone was extracted 
(section 2.2.5.1) to perform screening PCRs. As a control for the electroporation, 2.5x106 cells 
were treated as described previously being electroporated with no DNA. 
2.2.3 Protein expression analysis  
2.2.3.1 Fluorescence Activated Cell Sorting (FACS) 
To monitor the expression of GFP/VNP reporters, FACS analysis was performed on a FACS 
Calibur cytometer (Becton Dickinson). Cells were dissociated and 5x105 cells were resuspended 
in FACS buffer. Live cells were gated based on forward and side scatter and by propidium iodide 
dye exclusion. In each data acquisition 10000 gated events were recorded and the data 
obtained was subsequently analyzed using the FlowJo software. 
2.2.3.2         Immunocytochemistry  
Cells in coverslips were washed twice for 5min in PBS and fixed for 15min at 4ºC with 4% 
(w/v) paraformaldehyde (PFA) in PBS. Cells were washed twice for 5 min in PBS and residual 
PFA was washed with 0.1M Glycine in PBS for 10min at RT. Cells were permeabilized by 
incubation with 0.1% Triton in PBS for 10min at RT and blocked with blocking solution for 30 min 
at RT. Primary antibodies (see Table S5, Chapter 6) were diluted in blocking solution and 
incubated O/N at 4ºC. Cells were then washed three times with TBST for 5min. Appropriate 
secondary antibodies (see Table S5, Chapter 6) were diluted in blocking solution and incubated 
for 30min at RT. Cells were washed three times for 5min with TBST and counterstained with 
4',6-diamidino-2- phenylindole (DAPI) for 5min. After washing three times in PBS for 5min, cells 
in coverslips were mounted with Mowiol mounting medium. 
2.2.3.3 Determination of protein half-life 
At day 7 or day 8 of the neural differentiation protocol, cells in coverslips were treated with 
100 µg/mL of cycloheximide, an inhibitor of translation. Cells were then harvested after 30min, 
1h, 3h and 6h and immunocytochemistry was performed to detect expression of the GFP 
reporter (section 2.2.3.2). Alternatively, day 4 NPs were plated in MatTek dishes and rosettes 
were allowed to form. Cells were treated with cycloheximide at days 7 or 8 of the neural 
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differentiation protocol and time-lapse movies were performed during 6 or 12hrs. Cells were 
imaged on an inverted fluorescence Zeiss Axiovert 200M microscope in a chamber kept at 38 ºC 
with a humidified 5% CO2/95% air mix. Images were captured using a 40x/0.75 NA objective 
lens (Zeiss EC Plan-Neofluar) with an Hg-arc lamp and acquired with Metamorph software. 
Multiple points in the dish were chosen and cells were imaged with 30min or 1hr intervals. Data 
was analyzed using ImageJ software by measuring the average intensity of a maximum intensity 
projection of three Z planes of selected cells in the different time-points. The background was 
subtracted for each cell at each time-point.  
2.2.4 RNA expression analysis  
2.2.4.1 Isolation of total RNA from cultured ES cells  
To extract total RNA from the cells, 106 cells were collected and washed twice in PBS. The 
RNA was then extracted using the High Pure RNA Isolation Kit (Roche), according to the 
manufacturer‟s instructions, and quantified (section 6.1.1). 
2.2.4.2 cDNA synthesis 
To synthesize cDNA from the total RNA extracted it was used the Superscript II Reverse 
Transcriptase system, with random primers, according to the manufacturer‟s instructions. The 
cDNA obtained was used to perform standard PCR (section 6.1.3). 
2.2.5 DNA analysis  
2.2.5.1 Isolation of genomic DNA for screening PCRs 
For the extraction of genomic DNA for ES cell cultures, 106 cells were washed twice with ice-
cold PBS and immediately lysed with 1mL of SNET containing 400µg/mL of proteinase K. Cells 
were incubated O/N at 55ºC and then an equal volume of phenol:chlorophorm:isoamyl alcohol 
was added. The mixture was incubated for 30min at RT. The aqueous phase was collected after 
centrifugation at 2000rpm for 5min at RT. The DNA was precipitated by adding an equal volume 
of isopropanol with 1:10 sodium acetate and centrifuging at 13000g for 15min at 4ºC. Pellets 
were washed with 70% ethanol and resuspended in TE O/N at 4ºC. DNA was quantified (section 
2.2.6.1). 
2.2.5.2 Mycoplasma detection  
2.2.5.2.1 Control DNA extraction 
For high quality small-scale preparation of mycoplasma positive control plasmid DNA, 3mL of 
an O/N bacterial culture of transformed competent cells, in the appropriate selective LB medium, 
was processed using the Wizard Plus SV Minipreps DNA Purification System (Promega), 
according to the manufacturer‟s instructions. 
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2.2.5.2.2 PCR for Mycoplasma detection  
To check for the absence of mycoplasma contamination in ES cell cultures, samples were 
routinely collected using the following procedure. 106 cells were centrifuged at 2000rpm for 
5min, resuspended in wash buffer and centrifuged again in the same conditions. The pellet was 
then resuspended in a 1:1 mix of solution A and solution B and incubated for 1h at 60ºC. The 
suspension was denatured, to inactivate proteinase K, by incubation at 90ºC for 10min. 
The PCR for mycoplasma detection was performed using rTaq Polymerase, amplifying a 
conserved region in the 16S RNA gene. The amplification was performed with an initial step of 
denaturation at 95ºC for 5min, followed by 30 cycles of denaturation at 95ºC for 30sec, 
annealing at 58ºC for 1.5min and extension at 72ºC for 1.5min, and a final step of extension at 
72ºC for 10min. The reactions were prepared for a final volume of 25µL: 3µL of sample, 1x 
buffer, 0.2mM dCTP, 0.2mM dGTP, 0.2mM dATP, 0.2mM dTTP, 25pmol of each primer and 
2.5U of rTaq Polymerase. The PCR products were analyzed in agarose gel (section 6.1.2) The 
quality of the DNA preparation was confirmed by performing a PCR to detect GAPDH, a 
housekeeping gene that functions as an internal control. Also, a plasmid that carries an insertion 
that corresponds to the amplified fragment was used as a positive control (plasmid DNA was 
obtained as described in section 2.2.5.2.1). 
2.2.5.3 Purification and precipitation of plasmid DNA for electroporation  
To obtain high quality large-scale preparations of the plasmids to be electroporated into ES 
cells, 50 mL of bacterial culture of transformed competent cells, in the appropriate selective LB 
medium, were processed using the High Speed Plasmid Midi Kit (Quiagen) according to the 
manufacturer‟s instructions. Precipitation of the plasmid was done by adding 1/10 of the solution 
volume of 3M sodium acetate and 9/10 of isopropanol followed by centrifugation for 30 min at 
13000 rpm. The pellet was washed with 70% ethanol in sterile water and resuspended in PBS in 
a sterile laminar flow. DNA was quantified (section 6.1.1) and DNA integrity was confirmed by 
agarose gel electrophoresis (section 6.1.2). 
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3. RESULTS 
To identify a cell line that allows monitoring of Notch activity and its dynamics, different 
mouse ES cell lines expressing two different reporter proteins driven by the Hes5 promoter were 
tested: (i) HT cell line (Hes5::GFP), described by Tomishima and co-workers [1], that expresses 
a stable reporter protein; and (ii) Ha, Hc, Hd and derivatives (HdB5 and HdB8) and He cell lines 
(together named Hes5::VNP), that were generated in the Laboratory (section 2.2.2.1) and 
express the unstable reporter protein VNP (Figure 5). The 46C cell line, which is a Sox1:GFP 
knock-in [36], was used as a control for the experiments.  
 
Figure 5: Structure of Hes5::VNP reporter cassette and Screening PCRs scheme. The Hes5 BAC was modified 
replacing the coding region of Hes5 by the reporter cassette. The reporter cassette comprises a cDNA encoding the 
reporter protein Venus-NLS-PEST (VNP) and a Neomycin resistance cassette flanked by loxP sites. To validate the 
removal of Neomycin cassette several PCRs were performed, which are illustrated in the figure by the arrows. 
3.1 HT reporter ES cell line 
The HT cell line was already described by Tomishima and co-workers [1] and was further 
validated in terms of its stemness potential: self-renewal and pluripotency capacity. The half-life 
of the reporter protein was determined to assess its suitability as reporter of Notch activity.  
3.1.1 Self-renewal capacity 
The self-renewal capacity of HT cells was analyzed regarding the morphology, viability and 
fold increase (FI) of cell cultures. The morphology was assessed by direct observation of the 
cells in an inverted bright field microscope. It was observed that HT cells grew in typical ES 
morphology with cells being organized in clusters with almost no differentiation (Figure 6A-F).  
 
Figure 6: Self-renewal capacity of 46C, HT, Ha, Hc, Hd and He ES cell lines. (A-F) Bright field images of ES cells, 
organized in clusters. (G) The viability of the cell lines is not statistically different from that of the control cell line (46C). 
(H) FI values are within the normal range of variation of ES cells and are similar to those of 46C. These values 
represent the average of n passages from several replicates. (Scale-bar=100 µm)  
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Cells were passaged several times and the values of viability and FI were calculated as the 
average of several passages in many replicates. For each replica the viability was assessed, 
using the dye exclusion method by trypan blue and calculated by the ratio between the number 
of viable cells (that excluded the dye) and the total number of counted cells. The FI was 
determined by the ratio between the number of cells counted at the end of the passage and the 
initial number of plated cells. Viabilities and FI were observed to be similar to those of the control 
cell line (46C), confirming the self-renewal capacity of HT cells (Figure 6G,H). 
3.1.2 Pluripotency capacity 
The pluripotency capacity of HT cells was assessed regarding the ability to generate 
embryoid bodies (EBs) and, specially, the ability to undergo neural differentiation. 
3.1.2.1 Embryoid bodies formation 
To confirm the pluripotency capacity of the HT cells, the differentiation method through EBs 
was performed. HT cells generated EBs in a normal differentiation pattern (Figure S1).  
3.1.2.2 Neural differentiation in adherent monolayer cultures 
To further test the differentiation potential of HT cells into NPs, the neural differentiation 
protocol in adherent monolayer was performed [35]. Cell morphology was monitored daily on a 
bright field microscope and the formation of neuroepithelial rosettes was observed at day 8 of 
the protocol (Figure 7A). The values of viability and FI were analyzed at several time-points of 
the protocol (section 2.2.1.2.2). Both in high density and monolayer cultures, it was observed 
that HT cells had similar values of FI and viability to those of 46C cell line (Figure 7B,C).  
The efficiency of the protocol was assessed by FACS analysis using as a control the 46C cell 
line that expresses GFP under the control of the Sox1 promoter. Sox1 expression is activated in 
proliferating neuroectodermal cells, allowing to monitor the neural commitment efficiency [35], 
(reviewed in [36], [47]). At day 4, 80% GFP positive cells were observed, a value that was 
maintained at day 8 (Figure 7D), confirming the efficiency of the protocol. 
In HT cell line, FACS analysis performed at days 0, 4 and 8 of the protocol showed an 
increase in the expression of GFP along the protocol, with the reporter protein being expressed 
in approximately 60% of NPs at day 8 of the protocol. This increase was expected, since Notch 
starts to be active around day 3 [35] and is active in NPs at day 8 of the protocol. However, the 
levels of GFP expression are higher than the reported values that point out to 30% of the cells 
expressing Hes5 at a certain time-point in E3 chick neural tube [49]. Also, the percentage of 
GFP-expressing cells is variable between replicates and dependent on the efficiency of neural 
commitment, in clear contrast with 46C cell line in which this variability is not so evident. These 
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results were confirmed by immunocytochemistry performed at day 8, labeling the GFP reporter 
protein of 46C and HT cell lines. Cells were co-labeled with N-cadherin, marking apical 
adherents junctions, to allow the identification of the centre of each rosette (Figure 8A,B). 
 
Figure 7: Monolayer neural differentiation of HT and Hes5::VNP ES cell lines. (A) Bright field image of ES 
cultures along the monolayer neural differentiation protocol. All cell lines showed typical morphology at each time-
point being able to form neuroepithelial rosettes. (B,C) Values of viability and FI were similar to the ones of 46C cell 
line, both in High density and Monolayer cultures. (D) Analysis of the reporter proteins by FACS revealed that GFP is 
being expressed in approximately 60% of HT cells, while VNP is expressed only in Hd and He cell lines in 
approximately 5% of the cells. (Scale-bar=100µm) 
3.1.3 GFP half-life 
The suitability of the HT cell line as a good reporter of Notch activity was assessed by 
measuring the half-life of the reporter protein in neuroepithelial rosettes (section 2.2.3.3) using 
time-lapse movies and immunocytochemistry to visualize GFP. 
Three time-lapse movies were preformed from which 72 cells were analyzed. It was observed 
that 12hrs after the blockage of translation the expression of GFP in HT cells, as measured by 
the fluorescence intensity, is still 75% of the initial value (Figure 9A). These results were 
confirmed by immunocytochemistry measuring the fluorescence intensity of 230 cells at several 
time points. It was observed that 6hrs after inhibition of translation blockage the levels of GFP 
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expression are very similar to those of the initial time-point (Figure 9B). These results show that 
the HT cell line cannot be used to monitor Notch activity since the reporter protein perdures in 
the cell for much longer than the HES5 protein [42], impairing the observation of possible 
variations in levels of Notch activity. Therefore, a novel cell line that expresses a reporter protein 
with a half-life closer to that of the HES5 needs to be generated in order to be able to monitor 
the onset and termination of Notch activity.  
 
Figure 8: Immunocytochemistry of neuroepithelial rosettes preformed at day 8. Cells were labeled by 
immunocytochemistry using antibodies against N-cadherin (red), marking the apical junctions of the rosettes, and by 
GFP (green) marking the respective reporter protein: (A) 46C cells expressing GFP driven by the Sox1 promoter, (B) 
HT cells expressing GFP under the control of the Hes5 promoter (C) Hes5::VNP cells expressing VNP under the 
control of the Hes5 promoter. Nuclei are stained with DAPI. (Scale-bar=50µm) 
3.2 Ha, Hc, Hd, He reporter ES cell lines 
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Four Hes5::VNP ES cell lines (Ha, Hc, Hd and He) were generated in the Laboratory by the 
electroporation of a modified BAC vector, expressing an unstable yellow fluorescent reporter 
protein that localizes to the nucleus (VNP) under the control of the Hes5 promoter. Similarly to 
the analyses performed for the HT cell line (section 3.1), these novel cell lines were validated in 
terms of their stemness potential. 
 
Figure 9: Intensity of GFP expression in HT cells after translation blockage. (A) Fluorescence intensities 
measured in time-lapse movies of neuroepithelial rosettes: the values were calculated for each cell by the ratio 
between the fluorescence intensity of each time point and the fluorescence intensity of the initial time point. After 
12hrs of blockage of translation, the expression of GFP reporter is still ~75% of the initial value. (B) Fluorescence 
intensities measured in cells labeled with anti-GFP antibody: the values were calculated by the ratio between the 
fluorescence intensity of one cell at a certain time-point and the average of fluorescence intensities of all cells 
measured at the initial time-point. After 6hrs of translation inhibition the fluorescent ratio is similar to the initial value. 
The line represents the average between several replicates and for each time-point each dot represents one cell. 
3.2.1 Self-renewal capacity 
The morphology of the cells was assessed by their direct observation in an inverted bright 
field microscope. It was observed that all cell lines had a cluster-like ES morphology with almost 
no differentiation (Figure 6C-F). Furthermore, they all show values of FI and viability that were 
similar to the ones of 46C, confirming their self-renewal capacity (Figure 6G,H). 
3.2.2 Pluripotency capacity 
3.2.2.1 EB formation 
To confirm the pluripotency capacity of the cell lines, the differentiation method through EBs 
was performed. Hd and He generated EBs in a normal differentiation pattern (Figure S1C,D). 
3.2.2.2 Neural differentiation in adherent monolayer cultures 
As done with the HT cell line, the neural differentiation capacity of the four ES cell lines 
expressing the Hes5::VNP reporter was assessed. Cell morphology was observed daily on a 
bright field microscope and the formation of neuroepithelial rosettes was observed at day 8 of 
the protocol, confirming that the four cell lines were able to undergo neural commitment (Figure 
7A). The values of viability and FI were analyzed at several time-points of the protocol (days -1, 
0, 4 and 8). Both in the high density and monolayer cultures, it was observed that the four ES 
cell lines had similar values of FI and viability to those of the 46C cell line (Figure 7B,C). The 
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efficiency of the neural commitment was again confirmed by FACS analysis performed at day 8, 
using the 46C cell line as a control, which showed 80% of GFP-expressing cells  (Figure 7D).  
FACS analysis at days 0, 4 and 8 showed that only two of the four clones (Hd and He) had a 
slight increase in VNP expression along the protocol. Hd is the cell line expressing higher levels 
of VNP at day 8 of the protocol, ~5% (Figure 7D), a value that is lower than the expected 
compared with previously published data in E3 chick, where approximately 30% of cells have 
been shown to express Hes5 [49]. This might be due to the presence of the Neomycin 
resistance cassette before the polyadenylation signal, which could be causing the transcription 
of an incomplete reporter mRNA lacking a poly(A) tail sequence and that is potentially very 
unstable. The observed VNP expression levels for these novel cell lines are also lower than 
those observed for the HT cell line, as expected, since GFP expressed in HT cells is a stable 
reporter protein and consequently is not degraded as fast as the VNP reporter protein. VNP 
expression was confirmed by immunocytochemistry performed at day 8 (Figure 8C) using the 
same markers as in HT validation (GFP and N-cad) (section 3.1.2.2). It was also observed that 
the reporter is not expressed in all Hd and He cells, as expected, since Notch signaling is not 
active in all NPs at the same time (reviewed in [15]). Additionally, it was observed that the 
expression levels of the reporter protein are different between cells. This could mean that there 
are different levels of Notch activity between cells, but constant in each cell, or that Notch activity 
varies in individual cells and the differences observed result from the harvesting of cells in 
different phases of that variation. Overall these results suggest that the Hes5::VNP reporter cell 
lines might be adequate to monitor Notch activity, but the presence of Neomycin resistance 
cassette might be impairing VNP expression. 
3.2.3 Removal of Neomycin resistance cassette  
To allow the proper expression of the reporter protein, the Neomycin resistance cassette was 
removed. As this cassette is flanked by loxP sites, the Cre-loxP system was be used. Being Hd 
the Hes5::VNP cell line with the highest levels of expression of the reporter protein, it was 
chosen to proceed with the experiments.  
3.2.3.1 ES cell electroporation 
For the removal of the Neomycin selection cassette, Hd cells were electroporated with 
pTurbo-Cre, which encodes a Cre recombinase expressed under a strong promoter and that is 
targeted to the nucleus (increasing its efficiency), and pCAGGsPuromycin, which encodes a 
Puromycin resistance protein to allow for the selection of electroporated cells. The plasmids to 
be electroporated were isolated (section 2.2.5.3), quantified and the quality of the plasmids was 
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confirmed by the presence of a single band in an agarose gel (Figure S2) (an additional band 
indicates nicked plasmids, which cannot be used because they are more probable of integrating 
into the genome of the cells, causing subsequent deleterious effects). After electroporation, 
selection was performed with Puromycin for 2 days. Almost all cells detached from the plates but 
some small clusters remained attached and kept growing, in clear contrast with the negative 
control (cells electroporated without plasmid), where all cells detached (data not shown). When 
clusters started to be visible by eye (9 days after electroporation), 24 clusters were carefully 
picked (clones HdA1-A12 and HdB1-B12) and expanded. From the 11 clones that survived to 
the expansion, genomic DNA was extracted and used for PCR analysis (clones HdA2, HdA3, 
HdA8, HdA10, HdA11, HdB1, HdB4, HdB5, HdB7, HdB8, HdB11). 
3.2.3.2 Validation of Neomycin resistance cassette removal 
The removal of the Neomycin cassette was confirmed by the inability of cells to grow in 
Neomycin supplemented media and by PCR analysis. The self-renewal capacity of the clones 
was also analyzed to determine if any deleterious genomic effects occurred.  
3.2.3.2.1 Growth in Neomycin 
To identify the ES cell clones where the Neomycin cassette was excised, cells were grown in 
GMEM supplemented with 4µg/mL of Neomycin, for 4 days. From the 11 expanded clones, 7 of 
them were not able to grow upon Neomycin addition and, therefore, were good candidates to 
have excised the cassette (HdA2, HdA11, HdB1, HdB5, HdB7, HdB8, HdB11) (Table S1).  
3.2.3.2.2 PCR validation 
Several PCR reactions were performed in order to confirm the excision of the Neomycin 
cassette (see annealing regions of the primers in Figure 5). Specifically, a PCR to detect the 
Neomycin resistance gene and a PCR to detect the reporter cassette were used to confirm the 
results obtained by growth in Neomycin. The PCR to detect the reporter cassette amplifies a 
DNA fragment of 767 bp when the selection cassette is excised, but when the selection cassette 
is present the sequence between the annealing region of the primers is too long for PCR 
amplification. For all the clones, PCRs gave results that are coincident with the data from growth 
in Neomycin: clones where the selection cassette was removed have amplification of a DNA 
fragment correspondent to the PCR to detect the reporter cassette and no amplification of a 
DNA fragment correspondent to the Neomycin resistance gene (Figure 10). The results confirm 
that clones HdA2, HdA11, HdB1, HdB5, HdB7, HdB8, HdB11 excised the selection cassette. In 
addition, a PCR to detect Venus DNA was performed to ensure that it was not excised together 
with the Neomycin resistance cassette, due a recombination error. Only in the case of HdB7 
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clone the PCR did not amplify Venus DNA (Figure 10), and this clone was therefore discarded 
from future analyses. The quality of the DNA was assessed by PCR to detect GAPDH. 
 
Figure 10: Screening PCRs. The clones HdA2, HdA11, HdB1, HdB5, HdB8 and HdB11 fully respected the PCR 
selection criteria for Neomycin selection cassette removal: (i) amplification of a DNA fragment with the correct size of 
the reporter cassette PCR; (ii) no amplification of Neomycin resistance gene DNA; (iii) amplification of Venus DNA. 
3.2.3.3 Cell line choice 
The clones HdA2, HdA11, HdB1, HdB5, HdB8 and HdB11 respected all the criteria of 
Neomycin resistance cassette removal validation. No significant differences were observed 
between the clones, regarding the self-renewal capacity (morphology, viability and FI), except for 
HdA11 and HdB1 that had many differentiated cells (data not shown) and consequently were not 
chosen to proceed with the experiments. Initial data suggested that the cell lines with higher 
values of viability and FI were HdB5 and HdB8. These were then chosen to be used in the 
following experiments and for further validation in terms of self-renewal capacity and reporter 
protein expression, to assess their suitability as reporters of Notch activity. Also, PCRs were 
performed to assess the integration of the electroporated plasmids (pTurboCre and 
pCAGGsPuromycin) into the genome of the cells, which could cause deleterious effects. The 
absence of the plasmids was confirmed for both ES cell lines, since no DNA bands could be 
detected (Figure S3). The quality of the DNA was confirmed by a PCR to detect GAPDH.  
3.3 HdB5 and HdB8 ES cell lines  
HdB5 and HdB8, the cell lines generated by the removal of Neomycin cassette, were 
validated regarding their stemness capacity as described previously (sections 3.1.1 and 3.1.2). 
3.3.1 Self-renewal capacity 
No significant differences were observed in terms of morphology, viability and FI between 
HdB5 and HdB8 ES cell lines and the parental cell line (Hd) (Figure 11A-C). 
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Figure 11: Self-renewal capacity of HdB5 and HdB8 ES cell lines. (A-C) All analyzed cell lines show typical 
morphology of ES cells, organized in clusters. (D) The viability of both cell lines is similar to that of the control cell line 
46C. (E) Values of FI are within the normal range of variation of ES cells. These values represent the average of n 
passages from several replicates. (Scale-bar=100μm) 
3.3.2 Pluripotency capacity: neural differentiation in adherent monolayer cultures 
The neural differentiation capacity of both ES cell lines was assessed by the ability of the 
cells to undergo neural commitment, which was confirmed by the observation of neuroepithelial 
rosettes at day 8 of the protocol (Figure 12A). Additionally, analyses of morphology, viability and 
FI of the cells were performed. No differences were observed in morphology relative to the 
control cell line. The values of viability and FI were analyzed at several time-points of the 
protocol (section 2.2.1.2.2) showing similar values to those of the parental cell line both in high 
density and monolayer cultures (Figure 12B,C). 
 
Figure  12: Monolayer neural differentiation of HdB5 and HdB8 ES cell lines. (A) Morphology of ES cultures 
along the monolayer neural differentiation protocol. All cell lines had typical morphology at each time-point and all 
were able to form neuroepithelial rosettes. (B,C) Values of viability and FI are not statistically different from those of 
the control cell line Hd both in High density and Monolayer cultures. (D) Analysis of the expression of the reporter 
proteins by FACS revealed that VNP is not expressed in any of the HdB5 or HdB8 ES cell lines. These values 
represent the average of n passages from several replicates. (Scale-bar=100µm) 
To determine if the HdB5 and HdB8 cell lines show reporter expression in NPs, FACS 
analysis was performed along the differentiation protocol and immunocytochemistry at day 8. By 
either method, the analysis of the results showed that none of the clones were expressing the 
reporter protein (Figure 12D, Figure 13), in clear contrast with the parental cell line (Hd), which 
showed ~5% of the cells expressing the VNP reporter protein. This could be due to the low copy 
number of the reporter DNA due to multiple copy excision during the removal of Neomycin 
resistance cassette, coupled to the fast degradation of the reporter mRNA and protein, which 
might impair the visualization of VNP expression. In addition, damages in the promoter 
sequence or other signals necessary for transcription or translation might have occurred.  
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Figure  13: Immunocytochemistry of neuroepithelial rosettes (day 8) of HdB5 and HdB8 cell lines. Cells were 
labeled using antibodies against N-cadherin (red), marking the apical junctions of the rosettes and GFP (green), 
marking VNP reporter protein. Nuclei are stained with DAPI. (Scale-bar=50µm) 
3.3.3 Analysis of expression of VNP mRNA in HdB5 and HdB8 cell lines 
To assess if the lack of reporter expression in HdB5 and HdB8 was due to problems in 
translation or in transcription, the expression of the mRNA encoding the reporter protein was 
analyzed by RT-PCR for each cell line at days 0, 4 and 8 of the neural differentiation protocol 
(section 2.2.4). The quality of the cDNA produced was confirmed by a PCR to detect GAPDH 
and 46C cells were used as controls for the expression of endogenous Hes5 and reporter 
protein. In 46C cells it was observed that expression of the Hes5 increases along the protocol, 
as occurs also with the expression of reporter mRNA driven by the Sox1 promoter, as expected 
[35], [36]. This increase in Hes5 mRNA expression was also observed for Hd, HdB5 and HdB8 
cell lines confirming that cells are expressing the gene and that the lack of reporter expression is 
not due to deleterious effects on the signals necessary for Hes5 expression. 
In HT cells a precise relation between the levels of expression of endogenous Hes5 and the 
ones of the reporter mRNA was observed, with both increasing with the same magnitude along 
the protocol. In contrast, in HdB5 and HdB8 cells and in the parental cell line Hd, the increase in 
endogenous Hes5 expression from day 4 to day 8 is not followed by the same increase in the 
expression of the reporter mRNA. This shows that in Hd, HdB5 and HdB8 cells, reporter 
expression is not a good readout of endogenous Hes5 expression, suggesting that these cell 
lines might not be suitable to report Notch activity. Altogether these results also show that the 
lack of reporter expression is caused by impaired mRNA expression. When compared with the 
levels of expression of GFP mRNA in HT cells, the levels of expression of VNP mRNA in Hd, 
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HdB5 and HdB8 cells are very low, as expected since the VNP reporter is unstable at the mRNA 
level, in contrast with GFP mRNA in HT cells. However, the expression levels of VNP were lower 
in HdB5 and HdB8 than in the parental cell line Hd (Figure 14), which suggests that after the 
removal of Neomycin selection cassette, only one or very few copies of the reporter DNA 
remained, not being sufficient to drive detectable expression of the very unstable reporter 
mRNA/protein. In addition, the reduction in the number of copies of the reporter BAC DNA might 
have reduced the insulator effect on the surrounding chromatin, causing a silencing of reporter 
expression. Alternatively, the procedure for the removal of the Neomycin resistance cassette 
might have caused some mutations on the promoter regions that preclude the expression of the 
reporter protein. 
 
Figure 14: Analysis of Hes5 and reporter VNP mRNA expression at several time points of the neural 
differentiation protocol. The analysis of the expression of VNP mRNA shows that the levels of its expression were 
very low when compared to the levels of expression of endogenous Hes5 mRNA. The 46C and HT cell lines were 
used as controls, showing an increase in endogenous Hes5 expression along the protocol and an increase in reporter 
expression. The parental cell line Hd was also used as a control for the reporter mRNA expression. The quality of 
cDNA synthesis was assessed by performing a PCR to detect GAPDH.  
A PCR to detect the proximal promoter region of 676bp of the reporter DNA was thus performed 
in order to identify possible damages (like large insertions or deletions) that would impair the 
expression of the reporter protein (see primer annealing regions on Figure 5). It was observed 
that the DNA bands produced by PCR using DNA from HdB5 and HdB8 cell lines had a similar 
size to that obtained using DNA from the parental cell line Hd (in contrast with the negative 
control 46C), therefore confirming the integrity of the proximal promoter region of the reporter 
(Figure 15). These results show that the lack of reporter protein expression is not due to gross 
damages in the promoter region of the reporter protein cDNA. Overall analysis of the data 
relative to the expression of the reporter protein in HdB5 and HdB8 led to the conclusion that 
these cell lines are not good readouts of Notch activity, since the reporter protein is not being 
expressed in neuroepithelial rosettes, where Notch activity occurs.  
 
Figure 15: Hes5 promoter integrity. The integrity of the Hes5 promoter in the HdB5 and HdB8 cell lines was 
confirmed by PCR, where a fragment with the expected size and coincident with that of the parental cell line was 
obtained. 46C cell line was used as a negative control, where no band could be detected. 
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4. DISCUSSION 
In this work I have analyzed an already described Hes5::GFP reporter ES cell line (HT cell 
line), to test its suitability as a reporter to monitor Notch activity with high accuracy at the single 
cell level. I found that the HT cells express a reporter protein that perdures in the cell long after 
Notch activity is extinguished. Therefore, I have started the development of a novel cell line 
expressing a reporter protein with a short half-life that would allow the monitoring of Notch 
signaling dynamics. 
In the construction of a reporter cell line, one of the most important characteristics of the 
reporter protein is its half-life, especially when the endogenous protein whose expression is 
going to be monitored has short half-life, as is the case of HES5. In order to be able to detect the 
onset and termination of Notch activity the reporter protein must have a half-live close to that of 
HES5, which has been shown to be shorter that 1hr [42]. However, it should be noted that the 
experiments to determine the half-life of HES5 were not performed in neural progenitors and 
therefore the value for this type of cell might differ. I validated HT cells in terms of self-renewal 
capacity and analyzed their capacity to undergo neural differentiation, confirming the ability of 
HT cells to form neuroepithelial rosettes expressing the reporter protein. I also tested the half-life 
of the GFP reporter protein in HT cells to assess its suitability as a Notch activity reporter with 
fast response kinetics, confirming that it perdures in the cell for a long time after the stop of 
translation. Actually, 12 hrs after the blockage of translation, HT cells still express 75% of the 
initial values of GFP, in agreement with previous published data that report a half-life of 
approximately 26hrs for GFP. Therefore, I showed that HT cells should not be used as reporters 
to monitor Notch activity dynamics since GFP perdures in the cell after the termination of Notch 
activity. Additionally, I have observed that the expression levels of GFP in HT cell line at day 8 
are very variable between replicates and highly dependent on the efficiency of neural 
commitment and on the culture state, in contrast with the 46C cell line that has a more robust 
expression of GFP and is less dependent on the state of the culture. Altogether these results 
show that HT cells cannot be used to monitor dynamics of Notch activity.  
Due to the inadequacy of the HT cell line, I proceeded to the establishment of a novel cell 
line, with an unstable VNP reporter protein, whose expression would faithfully mimic the 
expression of the endogenous Hes5 gene. A similar reporter protein, unstable Venus-PEST, has 
already been used allowing the visualization of oscillations with 2hrs period in the expression of 
Lfng promoter [47]. This suggests that VNP is suitable to detect variations of HES5 expression if 
it has a similar period [42]. Several ES cell lines expressing the VNP reporter were generated 
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and validated, confirming no significant differences to the parental cell line in terms of self-
renewal and pluripotency capacities. Specifically, the neural differentiation capacity of these 
cells was confirmed, as well as the expression of the reporter protein. 
From the initial generated ES cell lines, Hd was validated and shown to express the reporter 
protein in neuroepithelial rosettes. However, Hd cells cannot be used as an adequate reporter of 
Notch activity since the reporter cassette comprises a Neomycin resistance gene that might be 
interfering with reporter expression because it is located between the coding region of VNP and 
the polyadenylation signal present at the 3‟UTR region. Therefore, in this cell line the reporter 
mRNA might be produced with the poly(A) signal from Neomycin gene or with no poly(A) signal. 
This might result in the production of a mRNA without the proper regulation signals or of a highly 
unstable mRNA impairing the detection of reporter expression. The cell lines in which the 
Neomycin resistance gene was removed showed self-renewal and pluripotency capacities 
similar to the control cell line. However, the cell lines selected to continue the experiments, HdB5 
and HdB8, were proven not to be suitable to reporter Notch activity since they do not express 
the reporter protein VNP, as observed by FACS analysis and confirmed by 
immunocytochemistry.  
To investigate whether the cause of lack of reporter protein expression was reduced 
transcriptional activity, the reporter expression was analyzed at the mRNA level. Analysis of the 
mRNA reporter expression in HdB5 and HdB8 showed that it was lower than in the parental cell 
line and not increasing along the differentiation protocol. These results were in clear contrast 
with the levels of expression of the endogenous Hes5 gene in the same cell lines that showed 
an increase from days 0 to 8. These results show that the reporter expression is not mimicking 
that of the endogenous Hes5 and suggest that the lack of reporter protein expression is due to 
problems at the level of reporter transcription and not to some deleterious effects affecting 
signals necessary for Hes5 expression. One possible explanation for the lack of reporter protein 
expression might reside on damages (insertions or deletions) in the reporter promoter region. 
This hypothesis was tested by the amplification of a DNA fragment from either cell line, 
comprising the proximal promoter region of the reporter bigger than the 400 bp that were 
described to be sufficient for transcriptional activation after Notch activity [50]. It was observed 
that in either case a fragment with the expected size and similar to that of the parental cell line 
(Hd) could be amplified, suggesting that no major deletion or insertion was made in the promoter 
region that could impair reporter protein expression. For a detailed analysis of the promoter 
region, sequencing would have to be performed. Also, these results exclude the hypothesis of 
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damages in the promoter region but do not exclude the existence of damages in the sequence 
of other regulatory transcriptional signals.  
Alternatively, upon the generation of Hes5::VNP cell lines, the modified BAC might have 
inserted in multiple copies in tandem, allowing the expression of the reporter. However, upon the 
excision of the selection cassette, some copies of the BAC might have also been excised by the 
recombination between loxP sites of different BAC copies, remaining only one copy of the 
construct after recombination. This one copy might have been silenced due to the inhibiting 
effects of the neighboring chromatin. Also it has been reported that repression at single-copy 
levels might occur because tandem repeats might amplify the effects of inhibitory or activating 
sequences present in the repeated sequence [51]. Additionally, the production of a highly 
unstable reporter mRNA, due to the presence of the Hes5 3‟UTR, that is degraded faster than 
the folding of the reporter protein might account for the inability to detect reporter expression. 
This would explain the expression of the reporter protein in Hd cells and the lack of expression 
in the cell lines where the selection cassette was removed.  
Despite the already described restrictions in the observation of reporter expression in Hd cells 
due to the presence of the Neomycin resistance cassette, it was observed by 
immunocytochemistry that in a neuroepithelial rosette not all cells express the reporter protein at 
the same levels, which suggests that the intensity of Notch activity varies between cells. This 
might be the result of cells having different levels of Notch activity between themselves but 
constant in each cell; also, this could mean that Notch activity is not constant, varying in each 
cell and that the observed differences are due to the harvesting of cells in different phases of 
that variation. These results suggest that there might be fluctuations of Notch activity, 
emphasizing the importance of monitoring Notch activity in single NPs.  
In order to overcome the limitations of the previous strategy to generate Hes5::VNP reporter 
cell lines and to engineer a cell line that would allow monitoring of Notch activity some other 
strategies have to be used. First, as there were generated four initial Hes5::VNP cell lines from 
which two were expressing the reporter protein (Hd and He), He cell line should be tested to 
assess its suitability as a Notch activity reporter and the Neomycin cassette should be removed. 
To generate new cell lines, it will be necessary to generate more initial clones, which would have 
different integration sites, increasing the probability of finding a cell line suitable for monitoring 
Notch activity. Also, upon the engineering planning of the cell lines, the construct should be 
designed so that the Neomycin resistance cassette will not need to be removed to allow the 
proper expression of the reporter and the visualization of the reporter protein expression. In this 
new strategy, the reporter DNA must have its own polyadenylation signal before the Neomycin 
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resistance cassette sequence to confer proper expression of the reporter protein, allowing its 
assessment before the removal of the Neomycin selection cassette. This would diminish the 
time and handling procedures for the cell line validation process and also the probabilities of 
genomic instability and damage inherent to ES cell culture.  
After the generation of novel ES cell lines expressing the VNP reporter protein under the 
control of the Hes5 promoter, it will be possible to monitor Notch activity and follow single NP 
cells. This will allow determining if Notch can have multiple activations in a life-time of a NP, if its 
activation occurs specifically in one phase of the cell cycle and if it is correlated with the fate of 
that NP being necessary to maintain cells in an undifferentiated state. Additionally, other BAC 
constructs can be electroporated into the Hes5::VNP cell line generated in order to create 
double reporter cell lines. This is the case of a BAC carrying a reporter of Delta1 expression that 
has already been generated in the Laboratory. The construction of a double reporter cell line in 
which Hes5 and Delta1 expression can be followed in real time and at the single cell level would 
allow following differentiated cells to determine the timing of commitment to neural 
differentiation. 
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6. SUPPLEMENTARY INFORMATION 
6.1 Supplementary Methods 
6.1.1 DNA/RNA quantification  
The concentration of each DNA/RNA preparation was determined by spectrophotometry 
using the NanoDrop spectrophotometer (Thermo Scientific). The sample concentration in ng/ul 
was calculated based on absorbance at 260 nm. The purity of the nucleic acid preparation was 
estimated by the ratio between the readings obtained at 260nm and 280nm (pure preparations 
of DNA show ratio values of 1.8 and pure RNA preparations have values closer to 2). 
6.1.2 Agarose gel electrophoresis 
To separate and estimate the size of DNA fragments, agarose gel electrophoresis was 
performed. Gels were prepared by heating until complete dissolution of agarose in 1x TAE 
buffer. The final agarose concentration depended on the size of DNA to be resolved and ranged 
from 1% to 1.5%. Samples were mixed with loading buffer in a 5:1 proportion and DNA was 
visualized under an ultraviolet light at 260nm or 365nm, by the addition of gel red. The size of 
the fragments was estimated by comparison with linear DNA strands of known molecular weight 
(1kb Plus DNA Ladder – Invitrogen). 
6.1.3 Screening PCRs 
Primers were designed to amplify specific target sequences (Table S4, Chapter 8). The 
reactions were prepared for a final volume of 25µL: 5µL of extracted genomic DNA (section 
2.2.5.1) or 5ul of cDNA (section 2.2.4.2), 1x buffer, 0.2mM dCTP, 0.2mM dGTP, 0.2mM dATP, 
0.2mM dTTP, 25pmol of each primer and 2.5U of DreamTaq Polymerase. The amplification was 
performed with an initial denaturation step at 94ºC for 5min, followed by 30 to 35 cycles of 
denaturation at 94ºC for 30sec, annealing at the specific temperature required for the primer set 
(Table S4) for 1min, extension at 72ºC for 1min, followed by 10min at 72ºC and 5min at 4ºC. 
6.1.4 Bioinformatics  
DNA, mRNA and Protein sequences were obtained from the NCBI 
(http://www.ncbi.nlm.nih.gov/) and Ensemble (http://www.ensembl.org/index.html) databases. 
Primer sequences were designed and analyzed using: Netprimer 
(http://www.premierbiosoft.com/netprimer/index.html) and Primer3 
(http://frodo.wi.mit.edu/primer3/). 
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6.2 Supplementary Results 
 
Figure S1: EB formation in 46C, HT, Hd and He ES cell lines. (A-D) Bright field images of EBs from the different 
cell lines studied, showing normal and typical morphology. (Scale-bar=100µm) 
 
Figure S2: Quality assessment of pTurboCre and pCAGGsPuromycin plasmids. The observed bands 
correspond to the visualization, in an agarose gel, of the plasmids. (A) pTurboCre plasmid. (B) pCAGGsPuromycin. 
Both plasmids were in proper conditions to be electroporated. 
 
Figure S3: PCRs to test for the integration of pTurboCre or pCAGGsPuromycin plasmids into HdB5 and 
HdB8 cell lines. The PCRs confirmed that neither plasmid integrated into the genome of either clone. For both PCRs 
positive controls consisting of plasmids containing the fragments to be amplified were used. In addition, for the PCR 
to detect the Puromycin resistance gene the 46C cells were used as a positive control since they contain a 
Puromycin resistance gene inserted into the genome.  
Table S1: ES cell growth in Neomycin supplemented media. (+) and (-) represent the ability of cells to grow or not 
in Neomycin supplemented media, respectively. 
ES clone HdA2 HdA3 HdA8 HdA10 HdA11 HdB1 HdB4 HdB5 HdB7 HdB8 HdB11 
Growth - + + + - - + - - - - 
 
6.2.1 LIF test 
To test the activity of new batches of LIF, the stemness potential of ES cells was tested in 
different conditions. For these studies a modified cell line was used, which expresses an 
unstable VNP reporter protein under the control of the Nanog promoter (a readout of the 
stemness state in ES cells) (Abranches et al, submitted). These cells can be analyzed by FACS 
to determine the percentage of cells expressing the Nanog::VNP reporter, which is typically 
around 50% when cells are grown in GMEM supplemented with LIF (data not published). Cells 
were plated at different cell densities and with different concentrations of LIF. Relatively to the 
cell density, cells were plated at: (i) normal density (3E+04 cells/cm2) to see if LIF is being able 
to maintain cells in an undifferentiated state in “normal” passages; and (ii) clonal density (1E+03 
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cells/cm2) to address if LIF is still able to do its function when cells are grown at a lower density 
and more dependent on the media. At normal density cells were analyzed during three 
passages in terms of morphology, viability, FI and Nanog::VNP expression. At clonal density the 
same characteristics were analyzed six days later. Relatively to LIF concentrations, three 
different concentrations were tested: the usual concentration 1/500, that corresponds to 2 
ng/mL, and the dilutions 1/250 and 1/1000. As controls, cells were plated without LIF [(-) ctrl], 
and with 1/500 dilution of the LIF from the previous lot [(+) ctrl]. Analysis of the data showed 
that, both at clonal and normal density, the three different LIF concentrations tested are able to 
sustain ES cell stemness state, in clear contrast to the negative control condition, where cells 
were totally differentiated. Namely, cell morphology, cell viabilities, FI and %Nanog::VNP 
positive cells were similar (Figure S6). 
 
Figure S 4: Lif test. (A-J) Cells were analyzed in terms of morphology, (K) viability, (M-N) FI and (L) Nanog::VNP 
expression, concluding that the new batch was as effective as the previous one. 
Table S2: ES cell lines used in the experiments described in this thesis. ES cells used are listed with the 
description and source. 
Cell line Description Source 
46C 
Mouse ES cell line derived from the E14Tg2a ES cell line, 
expressing the reporter protein GFP under the control of the 
Sox1 promoter 
Meng Li (MRC Clinical Sciences Centre, 
Faculty of Medicine, Imperial College, 
London, UK) and Austin Smith (Wellcome 
Trust Centre for Stem Cell Research, 
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Table S3: List of relevant reagents used in the experiments described in this thesis. The reagents are listed 
with information relative to suppliers, catalogue numbers and stock solutions. 
 
 
Table S4: List of relevant solutions used in the experiments described in this thesis. The composition of most 
important solutions is listed. The working stock characteristics of the solutions are listed in Table3.  
University of Cambridge, Cambridge UK) 
HT 
Mouse ES cell line derived from the E14Tg2a ES cell line, 
engineered by the insertion of a BAC vector, expressing the 
reporter protein GFP under the control of the Hes5 promoter 
Mark Tomishima (Sloan-Kettering 
Institute, Rockefeller University, New 
York, USA). 
 
Ha, Hc, 
Hd, He 
Mouse ES cell lines derived from the E14Tg2a ES cell line, 
engineered by the insertion of a BAC vector, expressing the 
unstable reporter protein VNP under the control of the Hes5 
promoter 
Cell lines engineered in the Laboratory 
HdB5, 
HdB8 
Mouse ES cell lines derived from the Hd ES cell line, 
expressing the unstable reporter protein VNP under the 
control of the Hes5 promoter 
Cell lines engineered in the Laboratory 
Nd 
Mouse ES cell line derived from the E14Tg2a ES cell line, 
expressing the reporter protein VNP under the control of the 
Nanog promoter 
Cell lines engineered in the Laboratory 
Reagent Supplier Cat. Number Stock Working Stock 
2-mercaptoethanol Sigma M-7522 RT 0.1 M in H20, 4ºC 
DAPI Sigma   1 mg/ml in 
PBS, -20ºC  
 
 
1.5 μg/ml in PBS, 4ºC 
DMSO Sigma D-2650   RT 
Dream Taq Fermentas  -20ºC -20ºC 
ESGRO COMPLETE PLUS Millipore Inc. SF001-100P -20ºC 4ºC 
Fast Red Roche 1149644900 -20ºC  
FBS ES-qualified Invitrogen 10439-024 -20ºC Heat-inactivate, -20ºC 
Gel red Biotium 41603-01 10000X, RT 500X 
Gelatin 2% 
 
 Sigma   
 
G-1393 4ºC 0.1% in PBS, 4ºC 
Glutamine GIBCO 25030-123 200mM 100x, -20ºC 
Glycine Sigma G-7403  RT 
GMEM GIBCO 21710-025  1x, 4ºC 
Laminin Sigma  L-2020 -20ºC -20ºC 
Mowiol Calbiochem    
murine bFGF Prepotech 100-18B -20ºC 4ºC 
Non-essential Aminoacids GIBCO 11140-035  100x, 4ºC 
PDL Sigma  P-7280 -20ºC -20ºC 
Pen-Strep   
 
GIBCO 15140-122   100x, -20ºC 
 
Propidium Iodide Invitrogen P-3566 1mg/mL, 4ºC 1ng/mL, 4ºC 
RHB-A 
StemCell Science 
Inc 
SCS-SF-NB-
01 
-20ºC 4ºC 
rTaq Polymerase GE Healthcare 27-0798-05 -20ºC -20ºC 
SeaKem LE Agarose Lonza    
Sodium Pyruvate GIBCO 11360-039 100mM 100x, -20ºC 
SuperScript II Reverse 
Transcriptase 
Invitrogen 18064-014 -20ºC -20ºC 
Trypsin GIBCO 25090-028 
2.5% (v/v), 
-20ºC 
0,25% or 0.025% in 
PBS,-20ºC/4ºC 
Cyclohexamide Sigma C-4859 4ºC 100mg/mL, 4ºC 
Solutions Components 
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Table S5: Oligonucleotide primers that were used in the experiments described in this thesis. The primers are 
listed with the respective sequences, annealing temperature, size of the amplified product and other observations 
(primers were provided by Sigma Genosys or Frilabo). 
 
Table S6: Antibodies used in the experiments described in this thesis. Antibody dilution, animal in which it was 
raised and origin are listed. 
 
1x TAE Buffer 40mM Tris; 1mM EDTA; 0.35% glacial acetic acid 
Blocking solution 10% (w/v) FBS; TBST 
FACS Buffer 4% (v/v) FBS; PBS 
Gelatin 0.1% 2% gelatin; PBS 
GMEM 1x 80% (v/v) GMEM; 1% (v/v) Glutamine; 1% (v/v) Pen-Strep; 1% (v/v) Sodium 
Pyruvate; 1% (v/v) non-essential Aminoacids; 10% (v/v) FBS; 0,001% (v/v) of 
2-mercaptoethanol 
Loading buffer 60% (v/v) Glycerol ; 10mM EDTA; 0.2% OrangeG 
Mowiol mounting medium 0.1% Mowiol; 33% glycerol; 0.1M Tris, pH 8.5;  
SNET 20mM Tris-HCl pH 8; 5mM EDTA pH 8; 0.4M NaCl; 1% (w/v) SDS 
Solution A 10mM Tris-HCl pH 8.3 ; KCl 100mM ; MgCl2 2.5mM 
Solution B 10mM Tris-HCl pH 8.3; MgCl2 2.5mM; 1% (v/v) Tween20; 1% (v/v) 
TritonX100; 120µg/mL proteinase K  
TBST for FISH  150mM NaCl; 0.1%Tween-20; 10mM KCl; 50mM Tris pH 7.5 
TBST for Immunocytochemistry 20mM Tris-HCl pH 8; 150mM NaCl; 0.05% Tween-20 
TE 10mM Tris; 1mM EDTA pH=8;  
Trypsin 0.025% 0.25% Trypsin; PBS 
Trypsin 0.25% 2,5% (v/v) Trypsin; 0.01% (v/v) chicken serum; 0.02% (v/v) 0.5M EDTA; PBS 
Wash buffer 10mM Tris-HCl pH 8.3 ; KCl 50mM ; MgCl2 1.5mM 
Marker 
Sense primer  
5’ to 3’ 
Anti-sense primer  
5’ to 3’ 
 
Annealing T. 
(ºC)  
Product 
size (bp) 
Obs 
Cre 
GCATAACCAGTGAAA
CAGCATTGCTG 
GGACATGTTCAGGG
ATCGCCAGGCG 
 61 270 
 
GAPDH 
ATTCAACGGCACAGT
CAAGG 
TGGATGCAGGGATG
ATGTTC 
 60 580 
 
Hes5 promoter 
TCCTCTGGAAGTCGC
TGTCT 
AGATCAGCTTCAGGG
TCAGC 
 
60 676 
5% 
formamide 
Mycoplasma 
TGCACCATCTGTCAC
TCTGTTAACCTC 
ACTCCTACGGGAGG
CAGCAGTA 
 
58 717 
 
Neomycin 
TGAATGAACTGCAGG
ACGAG 
AATATCACGGGTAGC
CAACG 
 56 515 
 
Puromycin 
GTCACCGAGCTGCAA
GAACT 
GCTCGTAGAAGGGG
AGGTTG 
 56 382 
 
Screenning 
TGGTCCTGCTGGAGT
TCGT 
TTAAGGATCATCGTG
GAGACC 
 65 767 
 
Venus 
ATGGTGAGCAAGGG
CGAGG 
CTTGTACAGCTCGTC
CATGCCG 
 
55 720 
 
Antibody anti- Dilution Animal Origin 
GFP 1:500 Mouse Abcam #ab1218 
GFP 1:400 Rabbit Abcam #ab290 
N-cadherin 1:200 Mouse BD Transduction Lab. #610920 
Sox2 1:200 Rabbit Chemicon #ab5603 
Tuj1 1:500 Mouse Covance # MMS-435P 
